A carregar...
Rindopepimut(®): A promising immunotherapeutic for the treatment of glioblastoma multiforme
Glioblastoma multiforme (GBM) is the most common and aggressive glial cell-derived primary tumor. Current standard of care for patients with GBM includes maximal tumor resection plus adjuvant radiotherapy and temozolomide chemotherapy, increasing median overall survival to a mere 15 months from diag...
Na minha lista:
| Publicado no: | Immunotherapy |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4524671/ https://ncbi.nlm.nih.gov/pubmed/25186601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.14.21 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|